Hyperhidrosis (HH) is a disorder involving the secretion of sweat in excess of that required for normal physiological thermoregulation. Most patients with HH experience some degree of functional and psychological dysfunction as a result of their condition. Despite this, a huge majority of patients do not recognise their excessive sweating as a medical condition. This article aims to cover the diagnosis, management and referral of patients with HH.
Get full access to this article
View all access options for this article.
References
1.
AmirM.ArishA.WeinsteinY.PfefferM.LevyY. (2000) Impairment in quality of life among patients seeking surgery for hyperhidrosis: Preliminary results. The Israel Journal of Psychiatry & Related Sciences37(1): 25–31. doi: 10.1111/j.1524-4725.2005.31106.
2.
BalajV.LangtryJ. A. (2007) Use of oral glycopyrronium bromide in hyperhidrosis. British Journal of Dermatology157: 118–121. doi: 10.1111/j.1365-2133.2007.07884.x.
3.
BensonR. A.PailinR.HoltP. J. E.LoftusI. M. (2013) Diagnosis and management of hyperhidrosis. British Medical Journal347(25): f6800, doi: 10.1136/bmj.f6800.
4.
CerfolioR. J.Ribas Milanez De CamposJ.BryantA. S.ConneryC. P.MillerD. L.de CampM. M.KrasnaM. J. (2011) The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis. The Annals of Thoracic Surgery91(5): 1642–1648. doi: 10.1016/j.athoracsur.2011.01.105.
5.
De AlmeidaA. R.MontagnerS. (2014) Botulinum toxin for axillary hyperhidrosis. Dermatologic Clinics32: 495, doi: 10.1016/j.det.2014.06.013.
6.
DrottC.GothbergG.ClaesG. (1995) Endoscopic transthoracic sympathectomy: An efficient and safe method for the treatment of hyperhidrosis. Journal of the American Academy of Dermatology33(1): 78–81. doi: 10.1016/0190-9622(95)90015-2.
7.
GrunfeldA.MurrayC. A.SolishN. (2009) Botulinum toxin for hyperhidrosis: A review. American Journal of Clinical Dermatology10(2): 87–102. doi: 10.2165/00128071-200910020-00002.
HerbstF.PlasE. G.FuggerR.FritschA. (1994) Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limbs. A critical analysis and long-term results of 480 operations. Annals of Surgery220(1): 86–90. doi: 10.1097/00000658-199407000-00012.
10.
HornbergerJ.GrimesK.NaumannM.GlaserD. A.LoweN. J.NaverH.StolmanL. P. (2004) Recognition, diagnosis and treatment of primary focal hyperhidrosis. Journal of the American Academy of Dermatology51(2): 274–286. doi: 10.1016/j.jaad.2003.12.029.
11.
HozleE.Braun-FalcoO. (1984) Structural changes in eccrine glands following long-term treatment with aluminium chloride hexahydrate. British Journal of Dermatology110(4): 399–403. doi: 10.1111/j.1365-2133.1984.tb04653.x.
12.
IbrahimO.KakarR.BolotinD.NodzenskiM.DisphanuratW.PaceN.AlamM. (2013) The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: A randomized controlled trial. Journal of the American Academy of Dermatology69(1): 88–95. doi: 10.1016/j.jaad.2013.02.013.
13.
KleinA. W. (2004) Contraindications and complications with the use of botulinum toxin. Clinics in Dermatology22(1): 66–75. doi: 10.1016/s0738-081x(03)00150-0.
14.
KowalskiJ. W.EadieN.DaggettS.LaiP. Y. (2004) Validity and reliability of the Hyperhidrosis Disease Severity Scale (HDSS). Journal of the American Academy of Dermatology50(3): 51, doi: 10.1016/j.jaad.2003.10.202.
15.
LearW.KesslerE.SolishN.GlaserD. A. (2007) An epidemiological study of hyperhidrosis. Dermatologic Surgery33: S69–S75. doi: 10.1111/j.1524-4725.2006.32334.x.
16.
LeucoufletM.LeuxC.FenotM.CelerierP.MaillardH. (2014) Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: A study of 28 patients. Journal of the American Academy of Dermatology70(6): 1083–1087. doi: 10.1016/j.jaad.2013.12.035.
17.
LoweN. J.YamauchiP. S.LaskG. P.PatnaikR.IyerS. (2002) Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: A double-blind, randomised, placebo-controlled study. Dermatologic Surgery28(9): 822–827. doi: 10.1097/00042728-200209000-00008.
18.
NaumannM.HammH.LoweN. J. (2002) Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: A randomized controlled trial. British Journal of Dermatology147(6): 1218–122. doi: 10.1046/j.1365-2133.2002.05059.x.
19.
NaumannM.LoweN. J. (2001) Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: Randomised, parallel group, double blind, placebo controlled trial. British Medical Journal323: 596, doi: 10.1136/bmj.323.7313.596.
SchiemanC.GelfandJ. G.GrondinS. C. (2010) Hyperhidrosis: Clinical presentation, evaluation and management. Expert Review of Dermatology5(1): 31–44. doi: 10.1586/edm.09.61.
23.
ShelleyW. B.HurleyH. J. (1975) Studies on topical antiperspirant control of axillary hyperhidrosis. Acta Dermato-Venereologica55(4): 241–260. doi: 10.1080/00015550152572831.
24.
SloanJ. B.SoltaniK. (1986) Iontophoresis in dermatology: A review. Journal of the American Academy of Dermatology14(4): 671–684. doi: 10.1016/s0190-9622(86)70223-5.
25.
SolishN.BertucciV.DansereauA.HongH. C.LyndeC.LuoinM.StorwichG. (2007) A comprehensive approach to the recognition, diagnosis and severity-based treatment of focal hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatologic Surgery33(8): 908–923. doi: 10.1097/00042728-200708000-00003.
26.
SolishN.WangR.MurrayC.A. (2008) Evaluating the patient with hyperhidrosis. Thoracic Surgery Clinics18(2): 133–140. doi: 10.1016/j.thorsurg.2008.01.002.
27.
StolmanL. P. (1987) Treatment of excess sweating of the palms by iontophoresis. Archives of Dermatology123(7): 893–896. doi: 10.1001/archderm.123.7.893.
28.
StruttonD. R.KowlakskiJ. W.GlaserD. A.StangP. E. (2004) US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national survey. Journal of the American Academy of Dermatology51(2): 241–248. doi: 10.1016/j.jaad.2003.12.040.
